Treatment and Control of Hypertension and Diabetes Mellitus Type 2
Individualised treatment targets in patients with type-2 diabetes and hypertension
... in treatment during follow up ...intensify treatment, even when faced with evidence of inadequate glycaemic ...drug treatment may all contribute to this unfortunate state of affairs [23, ...
11
Nutritional status, glycaemic control and barriers to treatment compliance among patients with type 2 diabetes attending public primary health clinics in Maseru, Lesotho
... uncontrolled hypertension despite being on treat- ment, and were not being monitored for complications of dia- betes, overall rendering their three-monthly visits to the clinics a revolving ...updated ...
13
Access and quality of care for users with hypertension and diabetes mellitus
... glycemic control, and adequate management of periodontal infections in patients with DM without glycemic control can restore normal glycemic values (BRASIL, ...diseases, hypertension and DM are the ...
5
TREATMENT PATTERN AND GLYCEMIC CONTROL OF ORAL HYPOGLYCAEMIC DRUGS AMONG TYPE II DM PATIENTS IN ERITREA
... globally, diabetes prevalence is similar in men and women, but it is slightly higher in men <60 years old and in women at older ages ...[10]. Hypertension was the commonly seen comorbid disease and this ...
6
The study of prevalence of hyperuricemia and metabolic syndrome in type 2 diabetes mellitus
... diseases. 2-4 Some reports on SUA and metabolic syndrome have noted that increased SUA concentration is associated with increased prevalence of some of the parameters of the metabolic syndrome like obesity, ...
9
<p>Hypertension and Its Associated Factors Among Type 2 Diabetes Mellitus Patients at Debre Tabor General Hospital, Northwest Ethiopia</p>
... aldosterone, a hormone responsible for retention of salt and water in the kidney to cause hypertension. 18 Apart from this, the presence of renal insuf fi ciency secondary to diabetes may impair the ability ...
11
Sitagliptin as combination therapy in the treatment of type 2 diabetes mellitus
... blind, randomized, placebo-controlled, cross-over study, 28 patients (baseline HgbA1c [A1c] ranging from 6.5% to 9%) received sitagliptin 50 mg twice daily or placebo for 4 weeks followed by the opposite treatment ...
8
Metabolic Syndrome: Consensus and Controversy: State of the Art
... Regarding the lifestyle changes, regular physical activity is a change in lifestyle that may influence favorably the results of cardiovascular health, including cardiovascular disease, stroke by stroke, ...
7
<p>A survey on glycemic control rate of type 2 diabetes mellitus with different therapies and patients’ satisfaction in China</p>
... 12 2) the course of diabetes is greater than or equal to 1 year; 3) oral administration of one or more hypoglycemic drugs and/or insulin for >3 months; 4) those with normal listening, speaking, reading ...
8
Alshalawi
... Type 2 diabetes has become prevalent ...countries. 2 The metabolic syndrome of truncal obesity, insulin resistance, type II diabetes mellitus, hypertension, and ...
5
Antimicrobial photodynamic therapy combined with periodontal treatment for metabolic control in patients with type 2 diabetes mellitus: study protocol for a randomized controlled trial
... between diabetes mellitus (DM) and periodontal disease is ...glycemic control and increases proteins found in the acute phase of inflammation, such as C-reactive ...the treatment of ...
6
Risk factors for osteoporosis in Japan: is it associated with <em>Helicobacter pylori</em>?
... (type 2 diabetes mellitus and hypertension); internal medical therapeutic agents (calcium channel blockers, HMG-CoA reductase inhibitors, and PPIs); serum parameters (hemoglobin [g/dL], ...
11
Assessment of three fasting plasma glucose targets for insulin glargine based therapy in people with type 2 diabetes mellitus in China: study protocol for a randomized controlled trial
... Secondary end points include: the control rate of HbA1c ≤6.5 % and HbA1c <7.0 % in patients who achieve their assigned FPG target; the percentage of pa- tients who achieve HbA1c <7 % without hypoglycemia per ...
7
Association between serum ferritin and type 2 diabetes mellitus
... Type-2 diabetes mellitus is an endocrinological disease associated with hyperglycemia characterized by both insulin resistance and defective insulin ...of diabetes, other associated ...
8
Relationship between diabetes mellitus and pulmonary tuberculosis and the outcome of treatment
... In the present study, the number of diabetics was 43.9% of the total patients included. The prevalence of DM in TB patients in Kerala is reported to be 44%10 while it was reported to be 15.2% in a study in Tamil Nadu. 11 ...
5
CLINICAL UTILITY OF C-PEPTIDE AND HbA1C MEASUREMENT IN THE MANAGEMENT OF TYPE-II DIABETESNuzhat Fatima*, Nahid Fatima Shaji Mohiuddin, Omer Imtiazuddin, Rabia Qureshi, Misba AliDOWNLOAD/VIEW
... term diabetes mellitus describes a metabolic disorder of multiple aetiology characterized by chronic hyperglycaemia with disturbances of carbohydrate, fat and protein metabolism resulting from defects in ...
9
Association of deletion allele of insertion/deletion polymorphism in α2B adrenoceptor gene and hypertension with or without type 2 diabetes mellitus
... and hypertension and that this association is more evident in patients with hypertension and ...with diabetes, so α 2B-AR polymorphism is one of the genetic factors involved in the prediction of ...
8
Prevalence and gender distribution of the metabolic syndrome
... obesity, hypertension and dyslipidaemia that increases the risk of the development of type 2 diabetes mellitus and cardiovascular ...lifestyle, diabetes mellitus, coron- ...
5
Serum uric acid level in type 2 diabetes mellitus
... Uric acid was significantly elevated in diabetic population. The serum uric acid level was independent of age and smoking status in males. Significant correlation was noticed between serum uric acid and BMI as well as ...
6
Cardiovascular Control during Exercise in Type 2 Diabetes Mellitus
... With respect to whole-body exercise, there is a lack of data about regional blood flows (in addition to contracting skeletal muscle) required to better understand how DM alters pulmonary VO ̇ 2 and its Fick ...
12